We describe the synthesis of 3,3,4,4,3',3',4',4'-homocystine-d(8) 2 in four
steps. Compound 2 has been utilized as an internal standard for the LC-MS
quantification of L-homocysteine 1, a marker for cardiac disease. 1,1,2,2-T
etradeutero-2-bromoethyl triphenylmethyl sulfide 4 was treated with the dia
nion of N-(tert-butoxycarbonyl) glycine tert-butyl ester 5 giving the homoc
ysteine derivative 6. Oxidation of 6 with iodine in methanol gave the homoc
ystine precursor 7. Subsequent deprotection provided 2 in high chemical pur
ity (99%) as measured by analytical HPLC and isotopic purity of >99% as det
ermined by mass spectrometry.